Home Healthcare Biotechnology Rapid Pathogen Detection Diagnostics Market

Rapid Pathogen Detection Diagnostics Market Size, Share & Trends Analysis Report By Product (Consumables & Reagents, Rapid Test Kits, Instruments, Software), By Technology (Next-Generation Sequencing, Immunoassays, Nucleic Acid Amplification Tests, Microfluidics, Others), By Application (Sexually Transmitted Infections, Respiratory Infections, Bloodborne & Hepatic Infections, Gastrointestinal Pathogens, Vector-Borne Diseases, Others), By End Use (Hospitals & Clinics, Diagnostic Laboratories, Point-of-Care, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: December 22, 2025 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Rapid Pathogen Detection Diagnostics Market, By Product 2022-2034 (USD MILLION/ Units)
    1. Consumables & Reagents
    2. Rapid Test Kits
    3. Instruments
    4. Software
  2. Rapid Pathogen Detection Diagnostics Market, By Technology  2022-2034 (USD MILLION/ Units)
    1. Next-Generation Sequencing 
    2. Immunoassays
    3. Nucleic Acid Amplification Tests
    4. Microfluidics
    5. Others
  3. Rapid Pathogen Detection Diagnostics Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Sexually Transmitted Infections
    2. Respiratory Infections
    3. Bloodborne & Hepatic Infections
    4. Gastrointestinal Pathogens
    5. Vector-Borne Diseases
    6. Others
  4. Rapid Pathogen Detection Diagnostics Market, By End Use 2022-2034 (USD MILLION/ Units)
    1. Hospitals & Clinics
    2. Diagnostic Laboratories
    3. Point-of-Care
    4. Others
  5. Regional Rapid Pathogen Detection Diagnostics Market
    1. North America
      1. North America Rapid Pathogen Detection Diagnostics Market By Product 2022-2034 (USD MILLION/ Units)
        1. Consumables & Reagents
        2. Rapid Test Kits
        3. Instruments
        4. Software
      2. North America Rapid Pathogen Detection Diagnostics Market By Technology  2022-2034 (USD MILLION/ Units)
        1. Next-Generation Sequencing 
        2. Immunoassays
        3. Nucleic Acid Amplification Tests
        4. Microfluidics
        5. Others
      3. North America Rapid Pathogen Detection Diagnostics Market By Application 2022-2034 (USD MILLION/ Units)
        1. Sexually Transmitted Infections
        2. Respiratory Infections
        3. Bloodborne & Hepatic Infections
        4. Gastrointestinal Pathogens
        5. Vector-Borne Diseases
        6. Others
      4. North America Rapid Pathogen Detection Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Diagnostic Laboratories
        3. Point-of-Care
        4. Others
      5. U.S.
        1. Consumables & Reagents
        2. Rapid Test Kits
        3. Instruments
        4. Software
        5. Next-Generation Sequencing 
        6. Immunoassays
        7. Nucleic Acid Amplification Tests
        8. Microfluidics
        9. Others
        10. Sexually Transmitted Infections
        11. Respiratory Infections
        12. Bloodborne & Hepatic Infections
        13. Gastrointestinal Pathogens
        14. Vector-Borne Diseases
        15. Others
        16. Hospitals & Clinics
        17. Diagnostic Laboratories
        18. Point-of-Care
        19. Others
      6. Canada
        1. Consumables & Reagents
        2. Rapid Test Kits
        3. Instruments
        4. Software
        5. Next-Generation Sequencing 
        6. Immunoassays
        7. Nucleic Acid Amplification Tests
        8. Microfluidics
        9. Others
        10. Sexually Transmitted Infections
        11. Respiratory Infections
        12. Bloodborne & Hepatic Infections
        13. Gastrointestinal Pathogens
        14. Vector-Borne Diseases
        15. Others
        16. Hospitals & Clinics
        17. Diagnostic Laboratories
        18. Point-of-Care
        19. Others
    2. Europe
      1. Europe Rapid Pathogen Detection Diagnostics Market By Product 2022-2034 (USD MILLION/ Units)
        1. Consumables & Reagents
        2. Rapid Test Kits
        3. Instruments
        4. Software
      2. Europe Rapid Pathogen Detection Diagnostics Market By Technology  2022-2034 (USD MILLION/ Units)
        1. Next-Generation Sequencing 
        2. Immunoassays
        3. Nucleic Acid Amplification Tests
        4. Microfluidics
        5. Others
      3. Europe Rapid Pathogen Detection Diagnostics Market By Application 2022-2034 (USD MILLION/ Units)
        1. Sexually Transmitted Infections
        2. Respiratory Infections
        3. Bloodborne & Hepatic Infections
        4. Gastrointestinal Pathogens
        5. Vector-Borne Diseases
        6. Others
      4. Europe Rapid Pathogen Detection Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Diagnostic Laboratories
        3. Point-of-Care
        4. Others
      5. U.K.
        1. Consumables & Reagents
        2. Rapid Test Kits
        3. Instruments
        4. Software
        5. Next-Generation Sequencing 
        6. Immunoassays
        7. Nucleic Acid Amplification Tests
        8. Microfluidics
        9. Others
        10. Sexually Transmitted Infections
        11. Respiratory Infections
        12. Bloodborne & Hepatic Infections
        13. Gastrointestinal Pathogens
        14. Vector-Borne Diseases
        15. Others
        16. Hospitals & Clinics
        17. Diagnostic Laboratories
        18. Point-of-Care
        19. Others
      6. Germany
        1. Consumables & Reagents
        2. Rapid Test Kits
        3. Instruments
        4. Software
        5. Next-Generation Sequencing 
        6. Immunoassays
        7. Nucleic Acid Amplification Tests
        8. Microfluidics
        9. Others
        10. Sexually Transmitted Infections
        11. Respiratory Infections
        12. Bloodborne & Hepatic Infections
        13. Gastrointestinal Pathogens
        14. Vector-Borne Diseases
        15. Others
        16. Hospitals & Clinics
        17. Diagnostic Laboratories
        18. Point-of-Care
        19. Others
      7. France
        1. Consumables & Reagents
        2. Rapid Test Kits
        3. Instruments
        4. Software
        5. Next-Generation Sequencing 
        6. Immunoassays
        7. Nucleic Acid Amplification Tests
        8. Microfluidics
        9. Others
        10. Sexually Transmitted Infections
        11. Respiratory Infections
        12. Bloodborne & Hepatic Infections
        13. Gastrointestinal Pathogens
        14. Vector-Borne Diseases
        15. Others
        16. Hospitals & Clinics
        17. Diagnostic Laboratories
        18. Point-of-Care
        19. Others
      8. Spain
        1. Consumables & Reagents
        2. Rapid Test Kits
        3. Instruments
        4. Software
        5. Next-Generation Sequencing 
        6. Immunoassays
        7. Nucleic Acid Amplification Tests
        8. Microfluidics
        9. Others
        10. Sexually Transmitted Infections
        11. Respiratory Infections
        12. Bloodborne & Hepatic Infections
        13. Gastrointestinal Pathogens
        14. Vector-Borne Diseases
        15. Others
        16. Hospitals & Clinics
        17. Diagnostic Laboratories
        18. Point-of-Care
        19. Others
      9. Italy
        1. Consumables & Reagents
        2. Rapid Test Kits
        3. Instruments
        4. Software
        5. Next-Generation Sequencing 
        6. Immunoassays
        7. Nucleic Acid Amplification Tests
        8. Microfluidics
        9. Others
        10. Sexually Transmitted Infections
        11. Respiratory Infections
        12. Bloodborne & Hepatic Infections
        13. Gastrointestinal Pathogens
        14. Vector-Borne Diseases
        15. Others
        16. Hospitals & Clinics
        17. Diagnostic Laboratories
        18. Point-of-Care
        19. Others
      10. Russia
        1. Consumables & Reagents
        2. Rapid Test Kits
        3. Instruments
        4. Software
        5. Next-Generation Sequencing 
        6. Immunoassays
        7. Nucleic Acid Amplification Tests
        8. Microfluidics
        9. Others
        10. Sexually Transmitted Infections
        11. Respiratory Infections
        12. Bloodborne & Hepatic Infections
        13. Gastrointestinal Pathogens
        14. Vector-Borne Diseases
        15. Others
        16. Hospitals & Clinics
        17. Diagnostic Laboratories
        18. Point-of-Care
        19. Others
      11. Nordic
        1. Consumables & Reagents
        2. Rapid Test Kits
        3. Instruments
        4. Software
        5. Next-Generation Sequencing 
        6. Immunoassays
        7. Nucleic Acid Amplification Tests
        8. Microfluidics
        9. Others
        10. Sexually Transmitted Infections
        11. Respiratory Infections
        12. Bloodborne & Hepatic Infections
        13. Gastrointestinal Pathogens
        14. Vector-Borne Diseases
        15. Others
        16. Hospitals & Clinics
        17. Diagnostic Laboratories
        18. Point-of-Care
        19. Others
      12. Benelux
        1. Consumables & Reagents
        2. Rapid Test Kits
        3. Instruments
        4. Software
        5. Next-Generation Sequencing 
        6. Immunoassays
        7. Nucleic Acid Amplification Tests
        8. Microfluidics
        9. Others
        10. Sexually Transmitted Infections
        11. Respiratory Infections
        12. Bloodborne & Hepatic Infections
        13. Gastrointestinal Pathogens
        14. Vector-Borne Diseases
        15. Others
        16. Hospitals & Clinics
        17. Diagnostic Laboratories
        18. Point-of-Care
        19. Others
      13. Rest of Europe
        1. Consumables & Reagents
        2. Rapid Test Kits
        3. Instruments
        4. Software
        5. Next-Generation Sequencing 
        6. Immunoassays
        7. Nucleic Acid Amplification Tests
        8. Microfluidics
        9. Others
        10. Sexually Transmitted Infections
        11. Respiratory Infections
        12. Bloodborne & Hepatic Infections
        13. Gastrointestinal Pathogens
        14. Vector-Borne Diseases
        15. Others
        16. Hospitals & Clinics
        17. Diagnostic Laboratories
        18. Point-of-Care
        19. Others
    3. APAC
      1. APAC Rapid Pathogen Detection Diagnostics Market By Product 2022-2034 (USD MILLION/ Units)
        1. Consumables & Reagents
        2. Rapid Test Kits
        3. Instruments
        4. Software
      2. APAC Rapid Pathogen Detection Diagnostics Market By Technology  2022-2034 (USD MILLION/ Units)
        1. Next-Generation Sequencing 
        2. Immunoassays
        3. Nucleic Acid Amplification Tests
        4. Microfluidics
        5. Others
      3. APAC Rapid Pathogen Detection Diagnostics Market By Application 2022-2034 (USD MILLION/ Units)
        1. Sexually Transmitted Infections
        2. Respiratory Infections
        3. Bloodborne & Hepatic Infections
        4. Gastrointestinal Pathogens
        5. Vector-Borne Diseases
        6. Others
      4. APAC Rapid Pathogen Detection Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Diagnostic Laboratories
        3. Point-of-Care
        4. Others
      5. China
        1. Consumables & Reagents
        2. Rapid Test Kits
        3. Instruments
        4. Software
        5. Next-Generation Sequencing 
        6. Immunoassays
        7. Nucleic Acid Amplification Tests
        8. Microfluidics
        9. Others
        10. Sexually Transmitted Infections
        11. Respiratory Infections
        12. Bloodborne & Hepatic Infections
        13. Gastrointestinal Pathogens
        14. Vector-Borne Diseases
        15. Others
        16. Hospitals & Clinics
        17. Diagnostic Laboratories
        18. Point-of-Care
        19. Others
      6. Korea
        1. Consumables & Reagents
        2. Rapid Test Kits
        3. Instruments
        4. Software
        5. Next-Generation Sequencing 
        6. Immunoassays
        7. Nucleic Acid Amplification Tests
        8. Microfluidics
        9. Others
        10. Sexually Transmitted Infections
        11. Respiratory Infections
        12. Bloodborne & Hepatic Infections
        13. Gastrointestinal Pathogens
        14. Vector-Borne Diseases
        15. Others
        16. Hospitals & Clinics
        17. Diagnostic Laboratories
        18. Point-of-Care
        19. Others
      7. Japan
        1. Consumables & Reagents
        2. Rapid Test Kits
        3. Instruments
        4. Software
        5. Next-Generation Sequencing 
        6. Immunoassays
        7. Nucleic Acid Amplification Tests
        8. Microfluidics
        9. Others
        10. Sexually Transmitted Infections
        11. Respiratory Infections
        12. Bloodborne & Hepatic Infections
        13. Gastrointestinal Pathogens
        14. Vector-Borne Diseases
        15. Others
        16. Hospitals & Clinics
        17. Diagnostic Laboratories
        18. Point-of-Care
        19. Others
      8. India
        1. Consumables & Reagents
        2. Rapid Test Kits
        3. Instruments
        4. Software
        5. Next-Generation Sequencing 
        6. Immunoassays
        7. Nucleic Acid Amplification Tests
        8. Microfluidics
        9. Others
        10. Sexually Transmitted Infections
        11. Respiratory Infections
        12. Bloodborne & Hepatic Infections
        13. Gastrointestinal Pathogens
        14. Vector-Borne Diseases
        15. Others
        16. Hospitals & Clinics
        17. Diagnostic Laboratories
        18. Point-of-Care
        19. Others
      9. Australia
        1. Consumables & Reagents
        2. Rapid Test Kits
        3. Instruments
        4. Software
        5. Next-Generation Sequencing 
        6. Immunoassays
        7. Nucleic Acid Amplification Tests
        8. Microfluidics
        9. Others
        10. Sexually Transmitted Infections
        11. Respiratory Infections
        12. Bloodborne & Hepatic Infections
        13. Gastrointestinal Pathogens
        14. Vector-Borne Diseases
        15. Others
        16. Hospitals & Clinics
        17. Diagnostic Laboratories
        18. Point-of-Care
        19. Others
      10. Taiwan
        1. Consumables & Reagents
        2. Rapid Test Kits
        3. Instruments
        4. Software
        5. Next-Generation Sequencing 
        6. Immunoassays
        7. Nucleic Acid Amplification Tests
        8. Microfluidics
        9. Others
        10. Sexually Transmitted Infections
        11. Respiratory Infections
        12. Bloodborne & Hepatic Infections
        13. Gastrointestinal Pathogens
        14. Vector-Borne Diseases
        15. Others
        16. Hospitals & Clinics
        17. Diagnostic Laboratories
        18. Point-of-Care
        19. Others
      11. South East Asia
        1. Consumables & Reagents
        2. Rapid Test Kits
        3. Instruments
        4. Software
        5. Next-Generation Sequencing 
        6. Immunoassays
        7. Nucleic Acid Amplification Tests
        8. Microfluidics
        9. Others
        10. Sexually Transmitted Infections
        11. Respiratory Infections
        12. Bloodborne & Hepatic Infections
        13. Gastrointestinal Pathogens
        14. Vector-Borne Diseases
        15. Others
        16. Hospitals & Clinics
        17. Diagnostic Laboratories
        18. Point-of-Care
        19. Others
      12. Rest of Asia-Pacific
        1. Consumables & Reagents
        2. Rapid Test Kits
        3. Instruments
        4. Software
        5. Next-Generation Sequencing 
        6. Immunoassays
        7. Nucleic Acid Amplification Tests
        8. Microfluidics
        9. Others
        10. Sexually Transmitted Infections
        11. Respiratory Infections
        12. Bloodborne & Hepatic Infections
        13. Gastrointestinal Pathogens
        14. Vector-Borne Diseases
        15. Others
        16. Hospitals & Clinics
        17. Diagnostic Laboratories
        18. Point-of-Care
        19. Others
    4. Middle East and Africa
      1. Middle East and Africa Rapid Pathogen Detection Diagnostics Market By Product 2022-2034 (USD MILLION/ Units)
        1. Consumables & Reagents
        2. Rapid Test Kits
        3. Instruments
        4. Software
      2. Middle East and Africa Rapid Pathogen Detection Diagnostics Market By Technology  2022-2034 (USD MILLION/ Units)
        1. Next-Generation Sequencing 
        2. Immunoassays
        3. Nucleic Acid Amplification Tests
        4. Microfluidics
        5. Others
      3. Middle East and Africa Rapid Pathogen Detection Diagnostics Market By Application 2022-2034 (USD MILLION/ Units)
        1. Sexually Transmitted Infections
        2. Respiratory Infections
        3. Bloodborne & Hepatic Infections
        4. Gastrointestinal Pathogens
        5. Vector-Borne Diseases
        6. Others
      4. Middle East and Africa Rapid Pathogen Detection Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Diagnostic Laboratories
        3. Point-of-Care
        4. Others
      5. UAE
        1. Consumables & Reagents
        2. Rapid Test Kits
        3. Instruments
        4. Software
        5. Next-Generation Sequencing 
        6. Immunoassays
        7. Nucleic Acid Amplification Tests
        8. Microfluidics
        9. Others
        10. Sexually Transmitted Infections
        11. Respiratory Infections
        12. Bloodborne & Hepatic Infections
        13. Gastrointestinal Pathogens
        14. Vector-Borne Diseases
        15. Others
        16. Hospitals & Clinics
        17. Diagnostic Laboratories
        18. Point-of-Care
        19. Others
      6. Turkey
        1. Consumables & Reagents
        2. Rapid Test Kits
        3. Instruments
        4. Software
        5. Next-Generation Sequencing 
        6. Immunoassays
        7. Nucleic Acid Amplification Tests
        8. Microfluidics
        9. Others
        10. Sexually Transmitted Infections
        11. Respiratory Infections
        12. Bloodborne & Hepatic Infections
        13. Gastrointestinal Pathogens
        14. Vector-Borne Diseases
        15. Others
        16. Hospitals & Clinics
        17. Diagnostic Laboratories
        18. Point-of-Care
        19. Others
      7. Saudi Arabia
        1. Consumables & Reagents
        2. Rapid Test Kits
        3. Instruments
        4. Software
        5. Next-Generation Sequencing 
        6. Immunoassays
        7. Nucleic Acid Amplification Tests
        8. Microfluidics
        9. Others
        10. Sexually Transmitted Infections
        11. Respiratory Infections
        12. Bloodborne & Hepatic Infections
        13. Gastrointestinal Pathogens
        14. Vector-Borne Diseases
        15. Others
        16. Hospitals & Clinics
        17. Diagnostic Laboratories
        18. Point-of-Care
        19. Others
      8. South Africa
        1. Consumables & Reagents
        2. Rapid Test Kits
        3. Instruments
        4. Software
        5. Next-Generation Sequencing 
        6. Immunoassays
        7. Nucleic Acid Amplification Tests
        8. Microfluidics
        9. Others
        10. Sexually Transmitted Infections
        11. Respiratory Infections
        12. Bloodborne & Hepatic Infections
        13. Gastrointestinal Pathogens
        14. Vector-Borne Diseases
        15. Others
        16. Hospitals & Clinics
        17. Diagnostic Laboratories
        18. Point-of-Care
        19. Others
      9. Egypt
        1. Consumables & Reagents
        2. Rapid Test Kits
        3. Instruments
        4. Software
        5. Next-Generation Sequencing 
        6. Immunoassays
        7. Nucleic Acid Amplification Tests
        8. Microfluidics
        9. Others
        10. Sexually Transmitted Infections
        11. Respiratory Infections
        12. Bloodborne & Hepatic Infections
        13. Gastrointestinal Pathogens
        14. Vector-Borne Diseases
        15. Others
        16. Hospitals & Clinics
        17. Diagnostic Laboratories
        18. Point-of-Care
        19. Others
      10. Nigeria
        1. Consumables & Reagents
        2. Rapid Test Kits
        3. Instruments
        4. Software
        5. Next-Generation Sequencing 
        6. Immunoassays
        7. Nucleic Acid Amplification Tests
        8. Microfluidics
        9. Others
        10. Sexually Transmitted Infections
        11. Respiratory Infections
        12. Bloodborne & Hepatic Infections
        13. Gastrointestinal Pathogens
        14. Vector-Borne Diseases
        15. Others
        16. Hospitals & Clinics
        17. Diagnostic Laboratories
        18. Point-of-Care
        19. Others
      11. Rest of MEA
        1. Consumables & Reagents
        2. Rapid Test Kits
        3. Instruments
        4. Software
        5. Next-Generation Sequencing 
        6. Immunoassays
        7. Nucleic Acid Amplification Tests
        8. Microfluidics
        9. Others
        10. Sexually Transmitted Infections
        11. Respiratory Infections
        12. Bloodborne & Hepatic Infections
        13. Gastrointestinal Pathogens
        14. Vector-Borne Diseases
        15. Others
        16. Hospitals & Clinics
        17. Diagnostic Laboratories
        18. Point-of-Care
        19. Others
    5. LATAM
      1. LATAM Rapid Pathogen Detection Diagnostics Market By Product 2022-2034 (USD MILLION/ Units)
        1. Consumables & Reagents
        2. Rapid Test Kits
        3. Instruments
        4. Software
      2. LATAM Rapid Pathogen Detection Diagnostics Market By Technology  2022-2034 (USD MILLION/ Units)
        1. Next-Generation Sequencing 
        2. Immunoassays
        3. Nucleic Acid Amplification Tests
        4. Microfluidics
        5. Others
      3. LATAM Rapid Pathogen Detection Diagnostics Market By Application 2022-2034 (USD MILLION/ Units)
        1. Sexually Transmitted Infections
        2. Respiratory Infections
        3. Bloodborne & Hepatic Infections
        4. Gastrointestinal Pathogens
        5. Vector-Borne Diseases
        6. Others
      4. LATAM Rapid Pathogen Detection Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Diagnostic Laboratories
        3. Point-of-Care
        4. Others
      5. Brazil
        1. Consumables & Reagents
        2. Rapid Test Kits
        3. Instruments
        4. Software
        5. Next-Generation Sequencing 
        6. Immunoassays
        7. Nucleic Acid Amplification Tests
        8. Microfluidics
        9. Others
        10. Sexually Transmitted Infections
        11. Respiratory Infections
        12. Bloodborne & Hepatic Infections
        13. Gastrointestinal Pathogens
        14. Vector-Borne Diseases
        15. Others
        16. Hospitals & Clinics
        17. Diagnostic Laboratories
        18. Point-of-Care
        19. Others
      6. Mexico
        1. Consumables & Reagents
        2. Rapid Test Kits
        3. Instruments
        4. Software
        5. Next-Generation Sequencing 
        6. Immunoassays
        7. Nucleic Acid Amplification Tests
        8. Microfluidics
        9. Others
        10. Sexually Transmitted Infections
        11. Respiratory Infections
        12. Bloodborne & Hepatic Infections
        13. Gastrointestinal Pathogens
        14. Vector-Borne Diseases
        15. Others
        16. Hospitals & Clinics
        17. Diagnostic Laboratories
        18. Point-of-Care
        19. Others
      7. Argentina
        1. Consumables & Reagents
        2. Rapid Test Kits
        3. Instruments
        4. Software
        5. Next-Generation Sequencing 
        6. Immunoassays
        7. Nucleic Acid Amplification Tests
        8. Microfluidics
        9. Others
        10. Sexually Transmitted Infections
        11. Respiratory Infections
        12. Bloodborne & Hepatic Infections
        13. Gastrointestinal Pathogens
        14. Vector-Borne Diseases
        15. Others
        16. Hospitals & Clinics
        17. Diagnostic Laboratories
        18. Point-of-Care
        19. Others
      8. Chile
        1. Consumables & Reagents
        2. Rapid Test Kits
        3. Instruments
        4. Software
        5. Next-Generation Sequencing 
        6. Immunoassays
        7. Nucleic Acid Amplification Tests
        8. Microfluidics
        9. Others
        10. Sexually Transmitted Infections
        11. Respiratory Infections
        12. Bloodborne & Hepatic Infections
        13. Gastrointestinal Pathogens
        14. Vector-Borne Diseases
        15. Others
        16. Hospitals & Clinics
        17. Diagnostic Laboratories
        18. Point-of-Care
        19. Others
      9. Colombia
        1. Consumables & Reagents
        2. Rapid Test Kits
        3. Instruments
        4. Software
        5. Next-Generation Sequencing 
        6. Immunoassays
        7. Nucleic Acid Amplification Tests
        8. Microfluidics
        9. Others
        10. Sexually Transmitted Infections
        11. Respiratory Infections
        12. Bloodborne & Hepatic Infections
        13. Gastrointestinal Pathogens
        14. Vector-Borne Diseases
        15. Others
        16. Hospitals & Clinics
        17. Diagnostic Laboratories
        18. Point-of-Care
        19. Others
      10. Rest of LATAM
        1. Consumables & Reagents
        2. Rapid Test Kits
        3. Instruments
        4. Software
        5. Next-Generation Sequencing 
        6. Immunoassays
        7. Nucleic Acid Amplification Tests
        8. Microfluidics
        9. Others
        10. Sexually Transmitted Infections
        11. Respiratory Infections
        12. Bloodborne & Hepatic Infections
        13. Gastrointestinal Pathogens
        14. Vector-Borne Diseases
        15. Others
        16. Hospitals & Clinics
        17. Diagnostic Laboratories
        18. Point-of-Care
        19. Others
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.